Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
ASO Visual Abstract: Evaluating the Impact of a Surgeon-Led Ductal Carcinoma In Situ Program on Endocrine Therapy Uptake.
Journal: Annals of surgical oncology
Published: February 25, 2026
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort studies.
Journal: JNCI cancer spectrum
Published: January 29, 2026
ASO Visual Abstract: Evaluating the Implementation and Maintenance of a Breast Cancer Risk Assessment and Prevention Program.
Journal: Annals of surgical oncology
Published: December 13, 2025
Cancer Health Disparities Among Patients With Early-Stage Estrogen Receptor-Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil.
Journal: JCO global oncology
Published: October 08, 2025
Tumor genomics in patients younger than 40 years of age with metastatic breast cancer.
Journal: NPJ precision oncology
Published: October 08, 2025
Evaluating the Implementation and Maintenance of a Breast Cancer Risk-Assessment and Prevention Program.
Journal: Annals of surgical oncology
Published: September 17, 2025
Evaluating the Impact of a Surgeon-Led Ductal Carcinoma in Situ Program on Endocrine Therapy Uptake.
Evaluating the Impact of a Surgeon-Led Ductal Carcinoma in Situ Program on Endocrine Therapy Uptake.
Journal: Annals of surgical oncology
Published: September 17, 2025
SMARCA4 pathogenic variants: Gynecological cancer histories from a laboratory tested cohort.
Journal: Gynecologic oncology
Published: August 14, 2025
Breast imaging recommendations for young females (age < 40 years) with ≥ 20% lifetime breast cancer risk: practice patterns at a specialized clinic.
Journal: Breast cancer research and treatment
Published: April 04, 2025
Frequency and clinical features of germline pathogenic variants in sarcoma: a case-control study.
Journal: Journal of the National Cancer Institute
Published: March 24, 2025
Corrigendum to "HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome" [Eur J Cancer 211 (2024) 114307].
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 19, 2025
A Phase Ib Study of Sapacitabine and Olaparib in Patients with BRCA1/2-Mutated Metastatic Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 13, 2025
Last Updated: 09/26/2026